Purification and characterization of rat liver naloxone reductase that is identical to 3alpha-hydroxysteroid dehydrogenase

References

• AHMED, M. K., FELSILD, R. L. and BACHUR, N. R., 1979, Comparison and characterization of mammalian xenobiotic ketone reductase. Journal of Pharmacology and Experimental Therapeutics, 209, 12–19.
   PubMed Web of Science ®Google Scholar
• CHATTERRE, N. and INTURRISI C. E., 1975, Stereospecific synthesis of the 613-hydroxy metabolites of naltrexone and naloxone. Journal of Medicinal Chemistry, 18, 490–492.
   Google Scholar
• CONE, E. J., 1976, General procedure for the isolation and identification of 6-a- and 613-hydroxy metabolites of narcotic agonists and antagonist with a hydromorphone structure. Journal of Chromatography, 129, 355–361.
   PubMedGoogle Scholar
• CONE, E. J., GORODETZKY C. W. and )(EH, S. Y., 1975, Biosynthesis, isolation and identification of 6fi-hydroxynaltrexone, a major human metabolite of naltrexone. Journal of Pharmaceutical Sciences, 64, 618–621.
   Google Scholar
• FELSTED, R. L. and BACHUR, N. R., 1980, Mammalian carbonyl reductases. Drug Metabolism Reviews, 11, 1–60.
   PubMed Web of Science ®Google Scholar
• FELSTED, R. L., RICHTER, D. R., Jos, D. M. and BACHUR, N. R., 1980, Isolation and characterization of rabbit liver xenobiotic carbonyl reductases. Biochemical Pharmacology, 29, 1503–1516.
   PubMed Web of Science ®Google Scholar
• FOLIN 0. and Wu, H., 1919, A method of blood analysis. Journal of Biological Chemistry, 38, 81–87. FUJIMOTO, J. M., 1969, Isolation of two different glucuronide metabolites of naloxone from the urine of rabbit and chicken. Journal of Pharmacology and Experimental Therapeutics, 168, 180–186.FUJIMOTO, J. M., 1970, Isolation of naloxone-3 -glucuronide from human urine. Proceedings of the Society for Experimental Biology and Medicine, 133, 317–319.
   Google Scholar
• FUJIMOTO, J. M., ROERIG S., WANG, R. I. H., CHATTERRE, N. and INTuRiusi, C. E., 1975, Narcotic antagonist activity of several metabolites of naloxone and naltrexone tested in morphine dependent mice. Proceedings of the Society for Experimental Biology and Medicine, 148, 443–448.
   Google Scholar
• GLATT, H. R., VOGEL, K., BENTLEY, P. and OESCH, F., 1979, Reduction of benzo(a)pyrene mutagenicity by dihydrodiol dehydrogenase. Nature, 277, 319–320.
   PubMed Web of Science ®Google Scholar
• IKEDA, M., HATTORI, H. and OHMORI, S., 1984, Properties of NADPH-dependent carbonyl reductase in rat liver cytosol. Biochemical Pharmacology, 33, 3957–3961.
   PubMed Web of Science ®Google Scholar
• JEz, J. M., FLYNN, T. G. and PENNING, T. M., 1997, A new nomenclature for the aldo-keto reductase superfamily. Biochemical Pharmacology, 54, 639–647.
   PubMed Web of Science ®Google Scholar
• KUMAGAI, Y., TODAKA, T., YAMANO S. and Tofu, S., 1990, Stimulation mechanism of guinea pig mediated reduction of naloxone by morphine. Drug Metabolism and Disposition, 18, 462–466. LAEMMLI, U. K., 1970, Cleavage of structural proteins during the assembly of the head of bacterophage T4. Nature, 227, 680–685.
   Google Scholar
• LOWRY, 0. H., ROSEBROUGH, N. J., FAR, A. L. and RANDALL, R. J., 1951, Protein measurement with the Folin phenol reagent. Journal of Biological Chemistry, 93, 265–275.
   Google Scholar
• MASER, E., 1995, Xenobiotic carbonyl reduction and physiological steroid oxidoreduction. Biochemical Pharmacology, 49, 421–440.
   PubMed Web of Science ®Google Scholar
• MATSUDA, K., TANAKA, Y., USHIYAMA S., OHNISHI, K. and YAMAZAKI, M., 1984, Inhibition of prostaglandin synthesis by sodium 244-(2-oxocyclopentylmethyl)-phenyThpropionate dihydrate (CS-600), a new anti-inflammatory agent, and its active metabolite in vitro and in vivo. Biochemical Pharmacology, 33, 2473–2478.
   Google Scholar
• MCMAHON, R. E., MARSHAL, F. J. and CLUP, H. W., 1965, The nature of the metabolites of acetohexamide in the rat and human. Journal of Pharmacology and Experimental Therapeutics, 149, 272–279.
   PubMed Web of Science ®Google Scholar
• OHARA, H., MIYABE, Y., DEYASHIKI, Y., MATSUURA, K. and HAR A., 1995, Reduction of drug ketones by dihydrodiol dehydrogenases, carbonyl reductase and aldehyde reductase of human liver. Biochemical Pharmacology, 50, 221–227.
   PubMed Web of Science ®Google Scholar
• PAWLOWSKI, J. E., HUIZINGA, M. and PENNING, T. M., 1991, Cloning and sequencing of the cDNA for rat liver 3a-hydroxysteroid/dihydrodiol dehydrogenase. Journal of Biological Chemistry, 266, 8820–8825.
   PubMed Web of Science ®Google Scholar
• PENNING, T. M., MUKHARJI, I., BARROWS, S. and TALALAY, P., 1984, Purification and properties of a 3a-hydroxysteroid dehydrogenase of rat liver cytosol and its inhibition by anti-inflammatory drugs. Biochemical Journal, 222, 601–611.
   PubMed Web of Science ®Google Scholar
• PENNING, T. M. and SHARP, R. B., 1987, Prostaglandin dehydrogenase activity of purified rat 3a-hydroxysteroid dehydrogenase. Biochemical and Biophysical Communications, 145, 1260-1265. PoLLocx, S. H., 1975, Dihydromorphinone ketone reductase. Life Sciences, 17, 465–476.
   Google Scholar
• RAPOPORT, H., BAKER, D. R. and REIST, H. N., 1957, Morphinone. Journal of Organic Chemistry, 22, 1489–1492.
   Web of Science ®Google Scholar
• RAPOPORT, H., HAUMANN, R., BISSELL, E. R. and BUNNER, R. M., 1950, The preparation of some dihydro ketones in the morphine series by oppenauer oxidation. Journal of Organic Chemistry, 15, 1103–1107.
   Google Scholar
• ROERIG S. C., CHRESTIANSEN, K. L., JANSEN, M. A., WANG, R. I. H., FUJIMOTO, J. M. and NICKERSON, M., 1980, Phylogenetic distribution of the hepatic enzyme system for reducing naloxone to 6a-and 6/3-naloxol in vertebrates. Comparative Biochemistry and Physiology, 65C, 93–97.
   Google Scholar
• ROERIG S., FUJEVIOTO, J. M., WANG, R. I. H., PoLLocx, S. H. and LANGE, D., 1976, Preliminary characterization of enzymes for reduction of naloxone and naltrexone in rabbit and chicken liver. Drug Metabolism and Disposition, 4, 53–58.
   Google Scholar
• SMITHGALL, T. E., HARVEY, R. G. and PENNING, T. M., 1986, Regio- and stereospecificity of homogeneous 3a-hydroxysteroid-dihydrodiol dehydrogenase for trans-dihydrodiol metabolites of polycyclic aromatic hydrocarbons. Journal of Biological Chemistry, 261, 6184–6191.
   PubMed Web of Science ®Google Scholar
• STOLZ, A., TAKIKAWA, H., SUGIYAMA, Y., KUHLENKAMP, J. and KAPLOWITZ, N., 1987, 3a-Hydroxysteroid dehydrogenase activity of the Y- bile acid binders in rat river cytosol. Identification, kinetics, and physiologic significance. journal of Clinical Investigation, 79,427-434. TAKIKAWA, H., FERNANDEZ -CHECA, J. C., KUHLENKAMP J., STOLZ, A., OOKHTENS, M. and KAPLOWITZ N., 1991, Effect of indomethacin on the uptake, metabolism and excretion of 3-oxocholic acid: studies in isolated hepatocytes and perfused rat liver. Biochimka et Biophyska Acta, 1084, 247–250.
   Google Scholar
• TAKIKAWA, H., STOLZ, A., KUROKI S. and KAPLOWITZ, N., 1990, Oxidation and reduction of bile acid orecursors by rat hepatic 3a-hydroxysteroid dehydrogenase and inhibition by bile acids and indomethacin. Biochimka et Biophysica Acta, 1043, 153–156.
   Google Scholar
• VOGEL, K., BENTLEY, P., PLATT, K. L. and OESCH, F., 1980, Rat liver cytoplasmic dihydrodiol dehydrogenase. Purification to apparent homogeneity and properties. Journal of Biochemical Chemistry, 255, 9621–9625.
   Google Scholar
• WARD, A. and CLISSOLD S. P., 1987, Pentoxifylline. A review of its pharmacodynamic and pharmaco-kinetic properties, and its therapeutic efficacy. Drugs, 34, 50–97.
   Google Scholar
• WEINSTEIN, S. H., PFEFFER, M., SCHOR, J. M., INDINDOLI, L. and MINTZ, M., 1971, Metabolites of naloxone in human urine. Journal of Pharmaceutical Sciences, 60, 1567–1568.
   PubMed Web of Science ®Google Scholar
• WERmni, B., 1985, Aldo-keto reductases. In T. G. Flynn and H. Weiner (eds), Enzymology of Carbonyl Metabolism 2 (New York: Alan R. Liss), pp. 209-230.
   Google Scholar
• YAMANO S., KAGEURA, E., IsHum, T. and Tofu, S., 1985, Purification and characterization of guinea pig liver morphine 6-dehydrogenase. Journal of Biological Chemistry, 260, 5259–5264.
   Google Scholar
• YAMANO S., ITO, K., OGATA, S. and Tom, S., 1997, Purification, characterization and partial primary structure of morphine 6-dehydrogenase from rabbit liver. Archives of Biochemistry and Biophysics, 341, 81–88.
   Google Scholar
• YAMANO S., NISHIDA, F. and TOM, S., 1986, Guinea-pig liver morphine 6-dehydrogenase as a naloxone reductase. Biochemical Pharmacology, 35, 4321–4326.
   Google Scholar